Equillium (EQ) Profit After Tax (2018 - 2026)
Equillium (EQ) posted quarterly Profit After Tax of -$5.3 million for Q1 2026, up 38.71% year-over-year from -$3.8 million in Q1 2025, and down 62.5% quarter-over-quarter from -$3.3 million in Q4 2025.
Equillium (EQ) Profit After Tax (2018 - 2026) Analysis & Trends
Equillium (EQ) has reported Profit After Tax for 9 consecutive years, with -$5.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 38.71% year-over-year to -$5.3 million; the TTM figure through Mar 2026 stood at -$18.7 million (down 38.6% YoY), while the FY2025 annual figure was -$22.4 million, down 201.62% from the prior year.
- Profit After Tax eased to -$5.3 million in Q1 2026 per EQ's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $2.4 million in Q4 2022 and bottomed at -$37.4 million in Q1 2022.
- Historically, Profit After Tax has averaged -$6.5 million across 5 years, with a median of -$3.9 million in 2023.
- Annual changes were most pronounced in 2022 — Profit After Tax soared 123.34% — and 2025, when it tumbled 1564.75%.
- Equillium's Profit After Tax stood at $2.4 million in 2022, then sank by 211.55% to -$2.7 million in 2023, then plunged by 83.92% to -$5.0 million in 2024, then jumped by 34.85% to -$3.3 million in 2025, then slumped by 62.5% to -$5.3 million in 2026.
- Business Quant data shows EQ's Profit After Tax at -$5.3 million in Q1 2026, -$3.3 million in Q4 2025, and -$4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 472.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,087.27 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | -4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.69 Mn |
| Mar 31, 2026 | -5.30 Mn |
| Dec 31, 2025 | -3.26 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -8.65 Mn |
| Dec 31, 2024 | -5.01 Mn |
| Sep 30, 2024 | -261,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | -2.73 Mn |
| Dec 31, 2023 | -2.72 Mn |
| Sep 30, 2023 | -3.71 Mn |
| Jun 30, 2023 | -3.34 Mn |
| Mar 31, 2023 | -3.94 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 30, 2022 | -13.31 Mn |
| Jun 30, 2022 | -14.13 Mn |
| Mar 31, 2022 | -37.42 Mn |
| Dec 31, 2021 | -10.46 Mn |
| Sep 30, 2021 | -10.28 Mn |